Frontline has reported a new India-focused politics development: “A dangerous prescription.” The publisher's feed describes the story as follows: The 10-year data protection regime sought by Big Pharma could create a new barrier to generic competition, raising drug costs and putting India’s affordable medicine ecosystem at serious risk. Intellectual Janata Party includes this item for public-affairs discovery and context only; readers should use the original publisher link for the complete rep
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.




